The study demonstrates that RIA is superior to ELISA for detecting VEGF in maternal serum, likely due to the formation of VEGF-protein complexes during pregnancy.
Answers are grounded in this paper and cite their sources.
ELISA unreliable for maternal VEGF; challenges prior ELISA-based studies and leaves open RIA validation for research.
Using radioimmunoassay (RIA) and a polyclonal antibody we have shown that maternal serum vascular endothelial growth factor (VEGF) is elevated during pregnancy. In contrast, a commercial VEGF ELISA utilizing a sandwich two-site immunoassay was unable to detect VEGF in 19 of the 20 maternal serum samples analysed. In addition, the recovery of exogenous VEGF added to the pregnancy samples was low or not recordable with the ELISA. Using RIA, 82-101% of the added VEGF was recovered. These differing results could be explained by the formation of VEGF-protein complexes that are detectable using RIA but undetectable with the ELISA. Our data imply that there is a substantial increase in circulating VEGF binding proteins during pregnancy. The increase in VEGF and its binding proteins during pregnancy may reflect important physiological events in the mother and feto-placental unit.
No takes yet. Share an insight, caveat, or question.
Anthony et al. (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: